World’s Costliest $2.1 Million Gene Therapy By Novartis Approved By FDA

World's Costliest $2.1 Million Gene Therapy By Novartis Approved By
FDA World's Most Expensive Gene Therapy Drug By Novartis – Worth $2.1
million has been given a green signal by the FDA. Zolgensma – is a
one-time gene therapy treatment for spinal muscular atrophy – a
disorder where there is weakness & wasting of muscles. […]

The post World's Costliest $2.1 Million Gene Therapy By Novartis
Approved By FDA appeared first on BioTecNika .

https://www.biotecnika.org/2019/05/worlds-costliest-2-1-million-gene-therapy-by-novartis-approved-by-fda/

Biotech News